Atiqah Nurul Wardhany
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Atiqah Nurul Wardhany has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Awalia
Department of Internal Medicine, Dr. Soetomo General Academic Hospital, Surabaya
1 shared publication - Azhraa Qinan Pranaya
Universitas Indonesia / Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia
1 shared publication - Mikiyas Gifawosen Teferi
School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
1 shared publication - Pang-Yun Chou
Department of Plastic and Reconstructive Surgery and Craniofacial Research Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
1 shared publication - Rebekah Juniati Setiabudi
Department of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya
1 shared publication - Yanuar Ari Pratama
Department of Plastic Reconstructive and Aesthetic Surgery, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in Biomolecular and Health Science Journal
- Vol. 9 (1) , 91-97
Challenging Penile Reconstruction in Adult Balanitis Xerotica Obliterans with Near-total Glans Fibrosis
Balanitis xerotica obliterans (BXO), the genital manifestation of lichen sclerosus, is a chronic inflammatory dermatosis that may cause progressive sclerosis and anatomical distortion. This case report presents a 58-year-old male with a 2-year history of penile deformity, circumferential hypopigmentation of the glans, sexual discomfort, and lower urinary tract symptoms. Initial assessment showed an International Prostate Symptom Score (IPSS) of 17 and an International Index of Erectile Function-5 (IIEF-5) score of 12. Physical examination revealed circumferential fibrosis with obliteration of the sulcus coronarius and destruction of approximately 70% of glans architecture, while the urethral meatus remained patent. Following excision of fibrotic tissue and penile mobilization, reconstruction was performed using a split-thickness skin graft (STSG) for a 3 cm × 5 cm circumferential defect. At 42-day follow-up, IPSS improved to 8 and IIEF-5–14. Advanced BXO may require reconstructive surgery, with STSG providing satisfactory functional and cosmetic outcomes.
- 1 January 2026
- Published by Wolters Kluwer Health in Biomolecular and Health Science Journal
- Vol. 9 (1) , 91-97
Open AccessChallenging Penile Reconstruction in Adult Balanitis Xerotica Obliterans with Near-total Glans Fibrosis
Balanitis xerotica obliterans (BXO), the genital manifestation of lichen sclerosus, is a chronic inflammatory dermatosis that may cause progressive sclerosis and anatomical distortion. This case report presents a 58-year-old male with a 2-year history of penile deformity, circumferential hypopigmentation of the glans, sexual discomfort, and lower urinary tract symptoms. Initial assessment showed an International Prostate Symptom Score (IPSS) of 17 and an International Index of Erectile Function-5 (IIEF-5) score of 12. Physical examination revealed circumferential fibrosis with obliteration of the sulcus coronarius and destruction of approximately 70% of glans architecture, while the urethral meatus remained patent. Following excision of fibrotic tissue and penile mobilization, reconstruction was performed using a split-thickness skin graft (STSG) for a 3 cm × 5 cm circumferential defect. At 42-day follow-up, IPSS improved to 8 and IIEF-5–14. Advanced BXO may require reconstructive surgery, with STSG providing satisfactory functional and cosmetic outcomes.
- Open Access
- 27 August 2024
- Published by Universitas Airlangga in Current Internal Medicine Research and Practice Surabaya Journal
- Vol. 5 (2)
COVID-19 Vaccination in Autoimmune Patients: A Literature Review
Patients with autoimmune diseases, especially rheumatic diseases, have their own concerns regarding the coronavirus disease 2019 (COVID-19) vaccination. Their concerns are specifically related to the physicological response, side effects, and effectiveness of the COVID-19 vaccination. COVID-19 and autoimmune diseases share some similarities in their clinical manifestations, immune responses, and pathogenic mechanisms. The correlation between COVID-19 vaccination and autoimmune diseases can be attributed to epitope mimicry, where the antigen contained in the vaccine has a structural similarity to self-antigen. The purpose of this literature review was to discuss the various types of vaccines, the side effects of the COVID-19 vaccination, and the effect of autoimmune patients' medication on the administration of the COVID-19 vaccination. According to several articles obtained in this study, most autoimmune patients typically experienced mild to moderate side effects. It was not advised for these patients to stop treatment before receiving the COVID-19 vaccination, as doing so was unlikely to affect the vaccine's effectiveness or the patients' immune response. The condition of the autoimmune patients was what influenced the immune response mediated by antibodies. Therefore, the COVID-19 vaccination must be administered when the patients are in a stable condition. In conclusion, it was determined that there is no restriction preventing autoimmune patients from receiving the COVID-19 vaccination. However, it should be noted that autoimmune patients are not recommended to receive live vaccines. Highlights:
- 27 August 2024
- Published by Universitas Airlangga in Current Internal Medicine Research and Practice Surabaya Journal
- Vol. 5 (2)
Open AccessCOVID-19 Vaccination in Autoimmune Patients: A Literature Review
Patients with autoimmune diseases, especially rheumatic diseases, have their own concerns regarding the coronavirus disease 2019 (COVID-19) vaccination. Their concerns are specifically related to the physicological response, side effects, and effectiveness of the COVID-19 vaccination. COVID-19 and autoimmune diseases share some similarities in their clinical manifestations, immune responses, and pathogenic mechanisms. The correlation between COVID-19 vaccination and autoimmune diseases can be attributed to epitope mimicry, where the antigen contained in the vaccine has a structural similarity to self-antigen. The purpose of this literature review was to discuss the various types of vaccines, the side effects of the COVID-19 vaccination, and the effect of autoimmune patients' medication on the administration of the COVID-19 vaccination. According to several articles obtained in this study, most autoimmune patients typically experienced mild to moderate side effects. It was not advised for these patients to stop treatment before receiving the COVID-19 vaccination, as doing so was unlikely to affect the vaccine's effectiveness or the patients' immune response. The condition of the autoimmune patients was what influenced the immune response mediated by antibodies. Therefore, the COVID-19 vaccination must be administered when the patients are in a stable condition. In conclusion, it was determined that there is no restriction preventing autoimmune patients from receiving the COVID-19 vaccination. However, it should be noted that autoimmune patients are not recommended to receive live vaccines. Highlights: